$54.36
+0.27 (+0.50%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-1.31%
1Y
+19.34%
YTD
+1.10%
Open$54.85
Previous Close$54.09
Day High$56.08
Day Low$54.08
52W High$78.48
52W Low$42.17
Volume—
Avg Volume1.59M
Market Cap5.22B
P/E Ratio—
EPS$-6.21
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$54.19
Above
SMA 200
$54.12
Above
RSI (14)
52.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
32 analysts
Price Target
+104.3% upside
Current
$54.36
$54.36
Target
$111.08
$111.08
$83.97
$111.08 avg
$162.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.76M | 2.63M | 1.10B |
| Net Income | -623,792,188 | -392,569,029 | -133,819,624 |
| Profit Margin | -16,569.8% | -15,741.3% | -12.2% |
| EBITDA | -691,894,678 | -459,618,169 | -179,167,841 |
| Free Cash Flow | — | — | -115,939,335 |
| Rev Growth | +43.0% | +43.0% | +24.0% |
| Debt/Equity | — | — | 0.61 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |